IITRI NEWS
NEWS
We are ready to answer your questions and provide guidance.
News
NCI Awards IITRI $29.8 Million for 2 New Programs
The National Cancer Institute’s Division of Cancer Treatment and Diagnosis (DCTD) has awarded IITRI $29.8 million for two major 5-year new programs. The DCTD supports many programs that facilitate the development of cancer therapeutics from the bench to the patient,...
ASCO 2016 Poster with Singh Biotechnology, LLC
ASCO 2016 Poster Presented IITRI co-authored a poster presented at the recent American Society of Clinical Oncology (ASCO) meeting in Chicago, IL. The poster, A novel single domain antibody (sdAb) SBT-100 to target intracellular STAT3 to affect growth and regression...
IITRI Announces Membership in NCBD Consortium
IITRI Joins National Chemical & Biological Defense Consortium IITRI is pleased to announce our acceptance as a member into the National Chemical & Biological Defense Consortium (NCBDC). The mission of the Consortium will be to provide the US Department of...
IITRI Announces Zika Mouse Model Available
IITRI is on the leading edge for testing new Zika vaccines and antivirals CHICAGO, May 9, 2016 /PRNewswire-USNewswire/ -- IIT Research Institute (IITRI) scientists have developed a novel mouse model for Zika infections using the current viral strain responsible for...
Poster: Rabbit Aerosol Infection Model for anthrax
ASM 2016 Poster: Rabbit Aerosol Model for B. anthracis A new IITRI poster presented at the recent ASM Biodefense and Emerging Diseases 2016 meeting is now available. In this poster, Winston Lin and colleagues describe the development of an aerosol model of infection...
IITRI Welcomes Robert Baker PhD as Division Manager
Please join us in welcoming Robert Baker, PhD as Division Manager. We’re pleased to announce Robert Baker, PhD as Assistant Vice President and Manager of the Microbiology and Molecular Biology Division at IITRI. Dr. Baker brings over 15 years of regulatory...
$9 million for the NCI PREVENT Cancer Program Contract
IIT Research Institute has been awarded a contract for up to $9 million for preclinical services to support the National Cancer Institute (NCI) Preclinical PREVENT Cancer Program - Toxicology and Pharmacology Testing. This NCI program was initiated to bring new...
IITRI’s Clinical Trial Support Services In the News
IITRI offers a wide range of bioanalytical services for the detection and quantification of both small molecule and biologic drug candidates from human clinical trial samples. Two recent publications highlight our experience in determining drug and hormone...
Notable contracts: Biological Surety Support for Plague Vaccine
Please click here for the article.
Recent Comments